Skip to main content
. 2010 Aug 6;3(2):287–293. doi: 10.1159/000318873

Fig. 1.

Fig. 1

Clinical presentation and MRI of the patient prior to the treatment (a, d), at the end of chemotherapy (b, e) and at the last visit after 18 months of imatinib (c, f).